Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GEORGE A VASQUEZ RIOS

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1386179349
CMS profile
11454542
Location
ALBUQUERQUE, NM

General Payments · PY2023–2024

$6,886.07

  • Reported across 32 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$6,798.60

27 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $2,633.12 5
Consulting Fee $2,362.50 1
Food and Beverage $1,802.98 21

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $3,004.62 5
Retrophin, Inc. $1,981.94 4
CALLIDITAS THERAPEUTICS US INC. $1,434.94 4
Aurinia Pharma U.S., Inc. $166.96 3
Amgen Inc. $64.09 3
Novo Nordisk AS $43.92 2
GlaxoSmithKline, LLC. $43.05 3
Acerta Pharma LLC $38.55 2
Daiichi Sankyo Inc. $20.53 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $87.47 5
PY2024 $6,798.60 27

Payment records · PY2024 (27)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $13.91 04/09/2024 Food and Beverage Undisputed 01/23/2026 1117405752 CMS
Amgen Inc. $20.93 10/04/2024 Food and Beverage Undisputed 01/23/2026 1117405754 CMS
Amgen Inc. $29.25 11/15/2024 Food and Beverage Undisputed 01/23/2026 1117405756 CMS
AstraZeneca Pharmaceuticals LP $18.05 03/13/2024 Food and Beverage Undisputed 01/23/2026 1104308154 CMS
AstraZeneca Pharmaceuticals LP $20.50 04/04/2024 Food and Beverage Undisputed 01/23/2026 1105415789 CMS
Aurinia Pharma U.S., Inc. $22.09 01/31/2024 Food and Beverage Undisputed 01/23/2026 1150693933 CMS
Aurinia Pharma U.S., Inc. $124.25 05/01/2024 Food and Beverage Undisputed 01/23/2026 1150693935 CMS
Aurinia Pharma U.S., Inc. $20.62 05/22/2024 Food and Beverage Undisputed 01/23/2026 1150693937 CMS
CALLIDITAS THERAPEUTICS US INC. $18.60 07/17/2024 Food and Beverage Undisputed 01/23/2026 1141518729 CMS
CALLIDITAS THERAPEUTICS US INC. $929.04 09/27/2024 Travel and Lodging Undisputed 01/23/2026 1141523565 CMS
CALLIDITAS THERAPEUTICS US INC. $360.00 09/27/2024 Food and Beverage Undisputed 01/23/2026 1141523567 CMS
CALLIDITAS THERAPEUTICS US INC. $127.30 10/23/2024 Travel and Lodging Undisputed 01/23/2026 1141525424 CMS
Daiichi Sankyo Inc. $20.53 05/29/2024 Food and Beverage Undisputed 01/23/2026 1089494438 CMS
GlaxoSmithKline, LLC. $15.00 01/29/2024 Food and Beverage Undisputed 01/23/2026 1116699545 CMS
GlaxoSmithKline, LLC. $14.53 08/07/2024 Food and Beverage Undisputed 01/23/2026 1116196909 CMS
GlaxoSmithKline, LLC. $13.52 09/14/2024 Food and Beverage Undisputed 01/23/2026 1116329584 CMS
Novartis Pharmaceuticals Corporation $54.16 09/11/2024 Food and Beverage Undisputed 01/23/2026 1087439870 CMS
Novartis Pharmaceuticals Corporation $5.41 09/11/2024 Food and Beverage Undisputed 01/23/2026 1087439872 CMS
Novartis Pharmaceuticals Corporation $31.29 10/08/2024 Food and Beverage Undisputed 01/23/2026 1087439878 CMS
Novartis Pharmaceuticals Corporation $551.26 10/27/2024 Food and Beverage Undisputed 01/23/2026 1087439882 CMS
Novartis Pharmaceuticals Corporation $2,362.50 10/27/2024 Consulting Fee Undisputed 01/23/2026 1087439884 CMS
Novo Nordisk Inc $22.61 05/15/2024 Food and Beverage Undisputed 01/23/2026 1097711330 CMS
Novo Nordisk Inc $21.31 07/12/2024 Food and Beverage Undisputed 01/23/2026 1097499735 CMS
Travere Therapeutics, Inc. $238.26 09/20/2024 Travel and Lodging Undisputed 01/23/2026 1149894919 CMS
Travere Therapeutics, Inc. $405.16 09/20/2024 Food and Beverage Undisputed 01/23/2026 1149894923 CMS
Travere Therapeutics, Inc. $1,280.45 09/20/2024 Travel and Lodging Undisputed 01/23/2026 1149894927 CMS
Travere Therapeutics, Inc. $58.07 10/14/2024 Travel and Lodging Undisputed 01/23/2026 1149894915 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.